Filing Flows › Camp4 Therapeutics (CAMP) › Q3 2026 › vs Q2 2026
Camp4 Therapeutics (CAMP) Q3 2026 vs Q2 2026 (quarter over quarter)
Camp4 Therapeutics's revenue rose $120K (+7%) from $1.8M in Q2 2026 to $1.9M in Q3 2026.
Camp4 Therapeutics, Q3 2026: revenue $1.9M (+139% year over year), operating margin -738.8%, net loss $29.0M, operating cash flow −$8.2M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.9M | $1.8M | $120K | +7% |
| Net loss | $29.0M | $33.5M | −$4.6M | -14% |
| Costs & expenses | $30.9M | $35.3M | −$4.5M | -13% |
| Operating costs | $15.9M | $15.2M | $769K | +5% |
| Interest & other, net | $14.9M | $20.1M | −$5.2M | -26% |
| Research & development | $11.4M | $10.8M | $617K | +6% |
| General & admin | $4.5M | $4.3M | $152K | +4% |
| Operating cash sources | $29.0M | $33.5M | −$4.6M | -14% |
| Depreciation & amortization | $523K | $515K | $8K | +2% |
| Share-based compensation | $2.0M | $1.9M | $93K | +5% |
| Working capital & other | $18.2M | $18.4M | −$154K | -0.8% |
| Cash used in operations | $8.2M | $12.7M | −$4.5M | -36% |
| Net loss absorbed | $29.0M | $33.5M | −$4.6M | -14% |
Questions
How much did Camp4 Therapeutics's revenue grow quarter over quarter in Q3 2026?
Camp4 Therapeutics's revenue rose $120K (+7%) from $1.8M in Q2 2026 to $1.9M in Q3 2026.